Cargando…
COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia
Hydroxychloroquine has gained popularity as a potential preventative and treatment of COVID-19 pneumonia due to its in vitro activity against the virus. These three cases of COVID-19 pneumonia of varying severities occurred in the setting of chronic hydroxychloroquine use. These cases argue against...
Autores principales: | Rahman, Awan K., Purdy, Adam G., Ender, Peter T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582078/ https://www.ncbi.nlm.nih.gov/pubmed/33123391 http://dx.doi.org/10.1155/2020/8822753 |
Ejemplares similares
-
Hydroxychloroquine/prednisone: COVID-19 pneumonia: 2 case reports
Publicado: (2021) -
Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia
por: Fernando, Emmaline Zantua, et al.
Publicado: (2021) -
Cladribine/hydroxychloroquine: COVID-19-pneumonia, lymphopenia and off label use: case report
Publicado: (2020) -
Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
por: Mori, Nobuaki, et al.
Publicado: (2021) -
Streptococcus pneumoniae Coinfection in COVID-19: A Series of Three Cases
por: Pal, Chaitanya, et al.
Publicado: (2020)